Abstract 6015: Comprehensive evaluation of three-dimensional (3D) culture systems as compound screening platforms with primary cancer cell lines
Chao Zhang,Qinghua Wu,Lei Jin,Deyin Chen,Xuzhen Tang,Hui Qi,Wenjie Gao,Qunsheng Ji
DOI: https://doi.org/10.1158/1538-7445.am2022-6015
IF: 11.2
2022-06-17
Cancer Research
Abstract:There are a number of challenges associated with personalized medicines. For example, many models revolve around the question of whether or not the in vitro models capture the relevant in vivo pathobiology and drug response information that may impact a patient's response to a therapy. Most in vitro oncology drug screening techniques are based on two-dimensional (2D) cell culture, which, to date, has failed to accurately imitate the physiological microenvironments due to the inherent limitations, such as the lack of interactions between intracellular and extracellular environments, or modifications in three-dimensional cell morphology, polarity, and division. These disadvantages prompted the development of models which would better simulate the microenvironment of tumor cells. Three-dimensional (3D) culture systems are becoming increasingly popular due to their ability to mimic natural cell characteristics and tissue-like structures compared with traditional 2D monolayer cell culture. Currently, multicellular spheroid and organoid cell culture are two popular 3D culture methods to evaluate drug activity. Spheroid cell culture utilizes ultra-low attachment plate to allow cells grow in spheroid format. Organoid cell culture is accomplished by growing cells in extracellular matrix scaffolds (such as Matrigel). In this study, we attempted to compare different drug screening platforms, including patient-derived xenograft (PDX) and two 3D cell cultures (spheroid and organoid). Compound sensitivity, genomics, pathology and expression of clinical marker were profiled. The purpose of this study is to identify an optimal model as a drug testing platform and a bridge between in vitro studies and animal experiments for identifying novel therapeutic targets. Citation Format: Chao Zhang, Qinghua Wu, Lei Jin, Deyin Chen, Xuzhen Tang, Hui Qi, Wenjie Gao, Qunsheng Ji. Comprehensive evaluation of three-dimensional (3D) culture systems as compound screening platforms with primary cancer cell lines [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr 6015.
oncology